The use of cannabis as medicine has not been rigorously tested due to production and governmental restrictions, resulting in limited clinical research to define the safety and efficacy of using cannabis to treat diseases. Preliminary evidence indicates that cannabis may help patients suffering from certain medical conditions and alleviate their pain.
Cannabis contains more than 100 different chemicals called cannabinoids. Each one has a different effect on the body. The most notable cannabinoid is the phytocannabinoid tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis. Cannabidiol (CBD) is the second most prevalent of the active ingredients of cannabis .While CBD is an essential non-psychoactive component of medical cannabis, THC is primarily responsible for its intoxicating, psychoactive effects. Strains have varying levels of both of these, plus some other cannabinoids and terpenoids which are volatile substances that generally give plants and flowers their flavour and fragrance. Each strain of cannabis has its own cannabinoid and terpenoid profile. In fact, cannabinoids and terpenoids work together in something called the “entourage effect”. The entourage effect simply means that cannabinoids such as THC and CBD, along with the hundreds of other compounds, including terpenoids, are meant to work together. It’s the whole plant that does the best job, not just a single compound. While relief does come from using a CBD oil or THC oil, whole plant therapy has been the most common use. One of the tests performed within Eurofins Netherlands is the profiling of these strains, which will provide guidance for future clinical studies to determine medicinal effects of products.

Li-Med is the Israeli representative of Eurofins BioPharma Product Testing Netherlands. We can assist and guide you in the right direction from import- export permit application set up to comprehensive testing performance. Our testing services include method developmentvalidation and stability studies to ensure product integrity is maintained over time.

Medicinal cannabis tests performed:

Basic cannabinoid profiling

Advanced cannabinoid profiling

Pesticides (Ph. Eur. 2.8.13)

Clinical trial documentation

Terpenoid profiling

Heavy metals (Arsenic, Cadmium, Lead, Mercury, Nickel and Zinc) by ICP


Microbiological Contamination

Assay and related substances (CBDA, CBD, CBN, CBNA etc.)


Combining Eurofin’s expertise in medical device testing with Li-Med’s expertise in regulation and quality assurance, we can develop an appropriate testing program that is tailored to the specific regulatory requirements and risk profile of each product.

Feel free to contact us:

  • This field is for validation purposes and should be left unchanged.